Long-term outcomes of active surveillance for clinically localized prostate cancer in a community-based setting: results from a prospective non-interventional study - Top-Institutions - MDSpire

Long-term outcomes of active surveillance for clinically localized prostate cancer in a community-based setting: results from a prospective non-interventional study

  • By

  • Jan Herden

  • Andreas Schwarte

  • Thorsten Werner

  • Uwe Behrendt

  • Axel Heidenreich

  • Lothar Weissbach

  • September 30, 2020

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urology
    • Oncology
    • Cancer Research

  • #2

    University of Toronto - Princess Margaret Cancer Centre
    University of Toronto - Princess Margaret Cancer Centre

    Toronto, ON

    Key Differentiators

    • Urology
    • Radiation Oncology
    • Cancer Epidemiology

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Urology
    • Oncology
    • Pathology

  • #4

    University College London Hospitals (UCLH)
    University College London Hospitals (UCLH)

    London, England

    Key Differentiators

    • Urology
    • Oncology
    • Clinical Research

  • #5

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Sweden

    Key Differentiators

    • Urology
    • Cancer Epidemiology
    • Clinical Trials

Original Source(s)

Long-term outcomes of active surveillance for clinically localized prostate cancer in a community-based setting: results from a prospective non-interventional study

  • by Jan Herden, Andreas Schwarte, Thorsten Werner, Uwe Behrendt, Axel Heidenreich, Lothar Weissbach

  • September 30, 2020

Related Content

One-year clinical outcomes of MR-guided stereotactic body radiation therapy with rectal spacer for patients with localized prostate cancer

The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating ‘trials within cohorts’ (TwiCs) for the evaluation of interventions for prostate cancer

Analysis of High-Dose-Rate Brachytherapy Outcomes in Prostate Cancer Patients Aged 75 and Older